HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q3 2022

SEC EDGAR SourceSEC Filings

Top Holdings61 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ONCONC
ADR

BEIGENE LTD-ADR

5.5M$737.8M19.4%$134.02+1.68%
16 qtrssince 2018-Q4
Unchanged
0

SALESFORCE.COM INC

2.4M$348M9.2%$206.97-29.92%
11 qtrssince 2020-Q1
Increased
63
JDJD
ADR

JD.COM INC-ADR

6.4M$320.1M8.4%$52.21-8.68%
16 qtrssince 2018-Q4
Decreased
0

DOORDASH INC - A

4.7M$232M6.1%$116.24-57.12%
8 qtrssince 2020-Q4
Unchanged
0
LEGNLEGN
ADR

Legend Biotech Corp. Sponsored ADR

5.1M$209.6M5.5%$46.09-12.98%
10 qtrssince 2020-Q2
Increased
69
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

11.1M$194.8M5.1%$36.87-58.32%
9 qtrssince 2020-Q3
Increased
71
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

2.2M$179M4.7%$102.06-26.25%
2 qtrssince 2022-Q2
Increased
66
VIPSVIPS
ADR

VIPSHOP HLDGS LTD

20.1M$169.4M4.5%$12.57-37.81%
7 qtrssince 2021-Q1
Decreased
0

CYTEK BIOSCIENCES INC

8.8M$128.9M3.4%$20.96-32.20%
5 qtrssince 2021-Q3
Unchanged
0
PDDPDD
ADR

PDD HOLDINGS INC

2M$125.9M3.3%$62.37-2.57%
2 qtrssince 2022-Q2
Increased
75
DQDQ
ADR

DAQO NEW ENERGY CORP

2.1M$111.5M2.9%$64.26-22.27%
3 qtrssince 2022-Q1
Increased
57

MONDELEZ INTERNATIONAL INC-A

1.9M$102.1M2.7%$33.70+54.24%
16 qtrssince 2018-Q4
Unchanged
0

GOSSAMER BIO INC

7.4M$88.9M2.3%$16.82-29.03%
15 qtrssince 2019-Q1
Unchanged
0

ON HLDG AG

5.5M$87.8M2.3%$30.90-44.01%
5 qtrssince 2021-Q3
Decreased
0
JKSJKS
ADR

JINKOSOLAR HLDG CO LTD

1.3M$71.5M1.9%$52.25-17.12%
2 qtrssince 2022-Q2
Increased
53
ENFNENFNDelisted

ENFUSION INC

5M$61.4M1.6%
4 qtrssince 2021-Q4
Unchanged
0

COUPANG INC

3.4M$56.3M1.5%$25.60-36.34%
5 qtrssince 2021-Q3
Unchanged
0

BRIDGEBIO PHARMA INC

5.4M$53.3M1.4%$28.25-63.90%
14 qtrssince 2019-Q2
Unchanged
0
IQIQ
ADR

IQIYI INC

15.4M$41.8M1.1%$18.39-84.94%
16 qtrssince 2018-Q4
Unchanged
0
YSYSG
ADR

Yatsen Holding Limited

34.9M$38.1M1.0%
$3.8B
AUM
61
Positions
Q3 2022
Filing
Rating · 2.0
Quarterly Portfolio Change
-4%Q2'21$9.7B-21%Q3'21$7.6B-15%Q4'21$6.5B-26%Q1'22$4.8B-3%Q2'22$4.7B-18%Q3'22$3.8B
Activity profile
$ moved · Q3'22
New7%Increased25%Decreased37%Exited32%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.0 years
<1Q5%1-4Q13%1-2Y23%2Y+59%

HHLR ADVISORS, LTD. manages $3.8B across 61 positions as of Q3 2022. Top holdings: ONC (19.4%), CRM (9.2%), JD (8.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q3 2022 Summary

Active quarter - 5 new positions, 8 exits, 12 increased. Top move: PDD (INCREASED, conviction 75). Portfolio: $3.8B across 61 positions.

Top holdings by portfolio weight

Total AUM$4B
ONC19.40%
CRM9.15%
JD8.42%
DASH6.10%
LEGN5.51%
BEKE5.12%
BABA4.71%
VIPS4.45%
CTKB3.39%
PDD3.31%
Other2.93%

Portfolio allocation by GICS sector

Sectors9
Healthcare34.85%
Consumer Cyclical31.76%
Technology18.71%
Real Estate5.12%
Consumer Defensive3.69%
Unknown2.99%
Communication Services2.62%
Basic Materials0.14%
Financial Services0.12%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Consumer Cyclical, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used